Evidence map›Paper›PMID 28018172›Full record

ArticleFrontiers in molecular neuroscience2016

APP Causes Hyperexcitability in Fragile X Mice.

Cara J Westmark, Shih-Chieh Chuang, Seth A Hays, Mikolaj J Filon, Brian C Ray, Pamela R Westmark, Jay R Gibson, Kimberly M Huber, Robert K S Wong

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. MDGA1 negatively regulates amyloid precursor protein-mediated synapse inhibition in the hippocampus.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. TestingFrontiers in molecular neuroscience · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Of Men and Mice: Modeling the Fragile X Syndrome.Frontiers in molecular neuroscience · 2018
    Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Cara J WestmarkDepartment of Neurology, University of Wisconsin-Madison, Madison Madison, WI, USA.
Shih-Chieh ChuangDepartment of Physiology and Pharmacology, State University of New York Downstate Medical Center Brooklyn, NY, USA.
Seth A HaysDepartment of Neuroscience, University of Texas Southwestern Medical Center Dallas, TX, USA.
Mikolaj J FilonDepartment of Neurology, University of Wisconsin-Madison, Madison Madison, WI, USA.
Brian C RayDepartment of Neurology, University of Wisconsin-Madison, Madison Madison, WI, USA.
Pamela R WestmarkDepartment of Medicine, University of Wisconsin-Madison, Madison Madison, WI, USA.
Jay R GibsonDepartment of Neuroscience, University of Texas Southwestern Medical Center Dallas, TX, USA.
Kimberly M HuberDepartment of Neuroscience, University of Texas Southwestern Medical Center Dallas, TX, USA.
Robert K S WongDepartment of Physiology and Pharmacology, State University of New York Downstate Medical Center Brooklyn, NY, USA.
University of Wisconsin–Madison · USThe University of Texas Southwestern Medical Center · USState University of New York · USSUNY Downstate Health Sciences University · US

Funding

Neurophysiological and acute pharmacological studies in FXS patientsU54HD082008 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI HUBER, KIMBERLY M. · 2014 to 2019
$9.8M
Mechanisms of mGluR-dependent synaptic plasticityR01NS045711 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI HUBER, KIMBERLY M. · 2003 to 2015
$4.6M
Cortical circuit changes and mechanisms in a mouse model of Fragile X SyndromeR01HD056370 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI GIBSON, JAY ROBERT · 2009 to 2012
$1.2M
Testing Direct Effects of mGluR5 Inhibition in an Alzheimer's Disease Mouse ModelR21AG044714 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI WESTMARK, CARA JEAN · 2013 to 2014
$408k
NIA NIH HHS R21 AG044714NICHD NIH HHS R01 HD056370NICHD NIH HHS U54 HD082008NINDS NIH HHS R01 NS045711
6 · The paper itself

Abstract

Amyloid-beta protein precursor (APP) and metabolite levels are altered in fragile X syndrome (FXS) patients and in the mouse model of the disorder,

Indexed as

amyloid-betaamyloid-beta precursor proteinfragile X mental retardation proteinfragile X syndromehyperexcitability

Identifiers

PMID28018172
PMCPMC5156834
OpenAlexW2562922463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.